July 13, 2014 | The American Lawyer
The Churn: Dickstein Group Defects, Plus More Lateral MovesGreenberg Traurig has raided Dickstein Shapiro for 13 lawyers and lobbyists in Washington, D.C., Paul Hastings plucks Kaye Scholer's white-collar and internal investigations chair and Troutman Sanders snags Hughes Hubbard's private equity chair in the latest round of lateral moves from throughout The Am Law 200.
By Brian Baxter
9 minute read
July 11, 2014 | The American Lawyer
LeBron's Lawyer Welcomes Return of King JamesFrederick Nance, a Cleveland-based regional managing partner at Squire Patton Boggs, has been the longtime personal and business lawyer to NBA star LeBron James, who on Friday announced that he would return to the Cleveland Cavaliers, a team he left four years ago this month. Nance admits that the advice he gave his star client about his the next stop in his playing career wasn't exactly unbiased.
By Brian Baxter
5 minute read
July 10, 2014 | The American Lawyer
Kirkland's $5 Million Man Leads on Texas Energy DealA little more than two months after Kirkland & Ellis made waves by heading to Houston with its hire of Andrew Calder from Simpson Thacher & Bartlett, the firm has snagged a key role advising longtime Simpson Thacher private equity client KKR on its creation of an oil and gas joint venture with Riverstone Holdings that will be one of the largest operators in Texas' Barnett Shale formation.
By Brian Baxter
6 minute read
July 09, 2014 | The American Lawyer
Cadwalader Takes Corporate Inversions to Another LevelCadwalader, Wickersham & Taft may have found a way to help more U.S. companies use corporate inversions to lower their tax bills. Salix Pharmaceuticals has retained the firm, as well as Covington & Burling and leading Irish shop A&L Goodbody, for its $2.7 billion acquisition of patents to gastrointestinal drugs owned by an Irish unit of Italy's Cosmo Pharmaceuticals.
By Brian Baxter
6 minute read
July 09, 2014 | The American Lawyer
Smolen, Kluger Speak About Careers Gone AwryTwo Am Law 100 lawyers who fell on hard times—Lee Smolen and Matthew Kluger—have recently discussed their trials and tribulations in vastly different venues.
By Brian Baxter
3 minute read
July 08, 2014 | The American Lawyer
The Churn: Venable Expands in L.A., Plus More Lateral MovesA day after Hogan Lovells and Squire Patton Boggs started the third quarter with mergers abroad, Venable has gotten into the tie-up game by picking up seven lawyers from Los Angeles litigation boutique Weingarten Brown. The Am Law Daily looks at those moves and more in our latest tally of Am Law 200 hires.
By Brian Baxter
10 minute read
July 07, 2014 | The American Lawyer
Skadden Deal Streak Continues for ADM, VGTOnly a few days after Skadden, Arps, Slate, Meagher & Flom topped the first half M&A league tables for legal advisers, the firm grabbed roles advising Video Gaming Technologies on its $1.3 billion sale to Aussie gambling-machine maker Aristocrat Leisure, as well as the Archer Daniels Midland Company on its $3.1 billion buy of natural ingredient flavoring firm Wild Flavors.
By Brian Baxter
6 minute read
July 07, 2014 | The American Lawyer
Hogan, Squire Make International Merger MovesGrowing global legal giants Hogan Lovells and Squire Patton Boggs both made major moves over the holiday weekend, with the latter expanding in Tokyo by absorbing a five-lawyer corporate boutique, while the former is poised to open two new offices in Latin America through its union with a 70-lawyer firm in Mexico.
By Brian Baxter
4 minute read
July 03, 2014 | The American Lawyer
The Churn: Holland & Knight Hires Again, Plus More Lateral MovesOnly days after confirming the closure of its Abu Dhabi office to focus on the Americas, Holland & Knight has brought on an 11-strong team by raiding an energy boutique for half of its lawyers. The Am Law Daily looks at those hires and more new arrivals from throughout the Am Law 200.
By Brian Baxter
6 minute read
July 02, 2014 | The American Lawyer
Biotech, Vitamin Deals a Boon to Wilson SonsiniSwiss drug giant Roche Holdings has agreed to pay up to $1.7 billion to buy Seragon Pharmaceuticals, a San Diego-based maker of breast cancer treatments being advised by Wilson Sonsini Goodrich & Rosati, which is also counseling online vitamin seller Vitacost.com on its $280 million sale to supermarket chain The Kroger Co.
By Brian Baxter
5 minute read
Trending Stories